Get startedLog in
    Picture of Fresenius SE & Co. KGaA logo

    FRE — Fresenius SE & Co. KGaA News Story

    0.000.00%
    de flag iconLast trade - 00:00
    HealthcareConservativeLarge CapNeutral
    All News

    Brief: Fresenius Kabi Reached A Global Settlement With Amgen Concerning Their Denosumab Biosimilars

    Picture of Fresenius SE & Co. KGaA logoFresenius SE & Co. KGaA
    27/03/2025 13:17
    March 27 (Reuters) - Fresenius Kabi:

FRESENIUS KABI: REACHED A GLOBAL SETTLEMENT WITH AMGEN CONCERNING THEIR DENOSUMAB BIOSIMILARS

FRESENIUS KABI: LAUNCH OF CONEXXENCE & BOMYNTRA IN THE U.S. IN MID-2025 AND IN EUROPE LATER IN H2 OF 2025

Further company coverage: AMGN.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Fresenius SE & Co. KGaA

    See all news